Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
39.47
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Kobayashi Pharmaceutical Total Liabilities (Quarterly) : 259.58M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 259.58M |
| March 31, 2026 | 288.74M |
| December 31, 2025 | 410.34M |
| September 30, 2025 | 334.55M |
| June 30, 2025 | 363.22M |
| March 31, 2025 | 298.86M |
| December 31, 2024 | 330.20M |
| September 30, 2024 | 320.11M |
| June 30, 2024 | 326.48M |
| March 31, 2024 | 371.89M |
| December 31, 2023 | 444.42M |
| September 30, 2023 | 377.42M |
| June 30, 2023 | 401.14M |
| March 31, 2023 | 406.42M |
| December 31, 2022 | 439.02M |
| September 30, 2022 | 349.46M |
| June 30, 2022 | 378.40M |
| March 31, 2022 | 412.24M |
| December 31, 2021 | 494.57M |
| September 30, 2021 | 430.43M |
| June 30, 2021 | 439.63M |
| March 31, 2021 | 434.05M |
| December 31, 2020 | 540.28M |
| September 30, 2020 | 448.89M |
| June 30, 2020 | 461.66M |
| Date | Value |
|---|---|
| March 31, 2020 | 476.47M |
| December 31, 2019 | 561.97M |
| September 30, 2019 | 513.09M |
| June 30, 2019 | 524.09M |
| March 31, 2019 | 494.74M |
| December 31, 2018 | 569.99M |
| September 30, 2018 | 525.90M |
| June 30, 2018 | 519.53M |
| March 31, 2018 | 532.42M |
| December 31, 2017 | 577.15M |
| September 30, 2017 | 514.45M |
| June 30, 2017 | 490.53M |
| March 31, 2017 | 472.74M |
| December 31, 2016 | 496.54M |
| September 30, 2016 | 517.05M |
| June 30, 2016 | 461.80M |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 389.58M |
| December 31, 2014 | 371.59M |
| September 30, 2014 | 387.93M |
| June 30, 2014 | 399.78M |
| March 31, 2014 | 426.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Medifast, Inc. | 64.02M |
| Integrated BioPharma, Inc. | 7.671M |
| Kao Corp. | 4.607B |
| Shiseido Co., Ltd. | 3.814B |
| Skinvisible, Inc. | 10.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.550B |
| Shareholders Equity (Quarterly) | 1.290B |
| Debt to Equity Ratio | 0.0034 |
| Current Ratio | 3.279 |
| Net Debt Paydown Yield | 0.01% |